BioAge Labs (BIOA) Short term Debt (2023 - 2026)

BioAge Labs (BIOA) has 4 years of Short term Debt data on file, last reported at $1.2 million in Q1 2026.

• For the quarter ending Q1 2026, Short term Debt fell 80.68% year-over-year to $1.2 million; the trailing twelve-month figure through Mar 2026 stood at $1.2 million (down 80.68% YoY), and the FY2025 full-year result was $2.6 million, down 55.87% from the prior year.
• Short term Debt eased to $1.2 million in Q1 2026, from $2.6 million in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $6.0 million in Q4 2023 to a low of $1.2 million in Q1 2026.
• A 4-year average of $4.7 million and a median of $5.8 million in 2023 frame the typical range for Short term Debt.
• Across the five-year window, Short term Debt changed 0.0% in 2024 and sank 80.68% in 2026, its largest moves.
• Tracing BIOA's Short term Debt over 4 years: stood at $6.0 million in 2023, then changed by 0.0% to $6.0 million in 2024, then tumbled by 55.87% to $2.6 million in 2025, then sank by 56.23% to $1.2 million in 2026.
• Business Quant data shows BIOA's Short term Debt at $1.2 million in Q1 2026, $2.6 million in Q4 2025, and $4.1 million in Q3 2025.